- Home
- RLMD vs TELA Comparison
RLMD vs TELA Comparison
Compare RLMD & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- TELA
- Stock Information
- Founded
- RLMD 2004
- TELA 2012
- Country
- RLMD United States
- TELA United States
- Employees
- RLMD N/A
- TELA N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- TELA Medical/Dental Instruments
- Sector
- RLMD Health Care
- TELA Health Care
- Exchange
- RLMD Nasdaq
- TELA Nasdaq
- Market Cap
- RLMD 66.7M
- TELA 63.0M
- IPO Year
- RLMD N/A
- TELA 2019
- Fundamental
- Price
- RLMD $1.99
- TELA $1.55
- Analyst Decision
- RLMD Hold
- TELA Buy
- Analyst Count
- RLMD 2
- TELA 3
- Target Price
- RLMD $1.00
- TELA $5.33
- AVG Volume (30 Days)
- RLMD 517.7K
- TELA 100.9K
- Earning Date
- RLMD 11-06-2025
- TELA 11-06-2025
- Dividend Yield
- RLMD N/A
- TELA N/A
- EPS Growth
- RLMD N/A
- TELA N/A
- EPS
- RLMD N/A
- TELA N/A
- Revenue
- RLMD N/A
- TELA $75,323,000.00
- Revenue This Year
- RLMD N/A
- TELA $25.72
- Revenue Next Year
- RLMD N/A
- TELA $22.03
- P/E Ratio
- RLMD N/A
- TELA N/A
- Revenue Growth
- RLMD N/A
- TELA 16.34
- 52 Week Low
- RLMD $0.24
- TELA $0.86
- 52 Week High
- RLMD $3.98
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- RLMD 59.73
- TELA 49.40
- Support Level
- RLMD $1.89
- TELA $1.47
- Resistance Level
- RLMD $2.84
- TELA $1.53
- Average True Range (ATR)
- RLMD 0.28
- TELA 0.09
- MACD
- RLMD 0.01
- TELA 0.01
- Stochastic Oscillator
- RLMD 37.96
- TELA 59.63
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.